ITMCTR2024000103
Not yet recruiting
Phase 2
A retrospective cohort study based on multi-center and propensity score matching was used to evaluate the effect of Tanreqing Injection on Influence of survival prognosis in patients with severe COVID-19 infection
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Conform to the criteria for moderate and severe diagnosis of the novel coronavirus infection Diagnosis and Treatment Protocol (Trial Version 9 and 10\); Diagnostic criteria for patients with viral pneumonia in (Trial Version 9 and 10\);
- •(2\)Age range from 18 to 75 years old (including 18 and 75 years old), gender is not limited.
Exclusion Criteria
- •Exclude patients who experience the endpoint death event within 48 hours of hospital admission.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multicenter retrospective observational study of effectiveness of mepolizumab in patients with severe eosinophilic asthma and comorbidities in Japan (J-Real-Mepo)JPRN-UMIN000045021Teikyo University School of Medicine200
Not yet recruiting
Not Applicable
APOLEON BT Studynresectable or recurrent biliary tract cancerJPRN-UMIN000053078Sasebo Kyosai Hospital500
Completed
Not Applicable
The multi-center cohort study investigating the relationship between subjective side effects of antidepressants and continuation of the therapy for depressiodepression of the first visit for psychiatryJPRN-UMIN000001015School of Medicine, Keio University Department of Neuropsychiatry500
Completed
Not Applicable
A multi-center retrospective observational study in patients with relapsed and refractory multiple myeloma receiving once-weekly carfilzomib dosing in combination with dexamethasone in a real-world setting in Japan (Weekly-CAR study)Multiple myelomaJPRN-UMIN000043049Ono Pharmaceutical Co., Ltd.150
Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206